Coverage
-
April 24, 2017
A New Jersey federal judge on Monday permanently blocked Amerigen Pharmaceuticals Inc. from moving forward with a generic version of Shire LLC's attention deficit hyperactivity disorder medication Adderall XR before the patents expire, pursuant to a settlement between the drugmakers.
1 other articles on this case.
View all »